Beckman Coulter expands DxI 9000 Immunoassay Analyzer menu
Beckman Coulter Diagnostics has announced that it has extended the menu of DxI 9000 Immunoassay Analyzer assays
Source: selectscience.net
Coulter Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Coulter Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Coulter Diagnostics Today - Breaking & Trending Today
Global Immunoassay Market Analysis, Strategies and Trends Report 2023-2024 & 2027: Dramatic Change for Traditional Immunoassay Technology as New Market Model Creates Enormous Opportunity
/PRNewswire/ -- The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides,...
Source: prnewswire.com
Beckman Coulter and Fujirebio Expand Partnership to Develop Patientfriendly Bloodbased Neurodegenerative Disease Diagnostics
Beckman Coulter Diagnostics a clinical diagnostics leader and Fujirebio a leader in neurological markers and In Vitro Diagnostic IVD manufacturing today announced an expansion of their partnership focused on development manufacturing and clinical adoption of neurodegenerative disease assays.
Source: businesswireindia.com
Danaher Corporation (NYSE:DHR) Q4 2023 Earnings Call Transcript
Danaher Corporation (NYSE:DHR) Q4 2023 Earnings Call Transcript January 30, 2024 Danaher Corporation beats earnings expectations. Reported EPS is $2.09, expectations were $1.9. Operator: Good morning. My name is Todd and I will be your conference facilitator this morning. At this time, I would like to welcome everyone to Danaher Corporation’s Fourth Quarter 2023 Earnings […]
Source: yahoo.com
Danaher Corporation (NYSE:DHR) Q3 2023 Earnings Call Transcript
Operator: Good morning. My name is Todd, and I will be your conference facilitator today.
Source: insidermonkey.com